Clinical
InCytomix’s advanced real-time PCR system offers an unrivalled approach to pathogen detection, such as SARS-CoV-2, RSV and SARS-CoV-2. Our unique platform ensures maximum multiplexing capabilities, combined with high detection sensitivity and specificity. Target DNA or RNA can be extracted and amplified from various sample types, including serum, plasma, and swabs.
Virology Services
Our virology services represent the cutting edge in detection, characterization, and analysis of viruses. We offer:
- Plaque Reduction Neutralisation Test (PRNT)
- Plaque Assay (PA)
- Quantitative (TCID50) and Qualitative Culture (Flask) Virus Subtyping
- Microneutralisation
- Resistance Characterisation
- Hemagglutinin Inhibition (HAI)
Diagnostic Immunology: To Identify and Evaluate Immune Responses
Our diagnostic immunology services utilise immunoassays to detect and measure patient antibody responses to bacteria, parasites, and viruses. This comprehensive offering includes:
- Cell-Based Assays: Advanced tools for comprehensive immune response evaluation.
- Neutralising Antibodies (NAb): Precise detection and evaluation of NAb to gauge the efficacy of immune responses.
- Potency Assays: Rigorous assessment of biological activity to ensure product consistency and quality.
- Semi-Quantitative Testing via Titers: Evaluate the strength of immune responses with accurate, semi-quantitative measurements.
- Advanced Techniques: Including PRNTs, FRNTs, and ELISA to determine the presence of antibodies specific to your identified infectious disease agent.
Customised Solutions for Specific Clinical Needs
InCytomix’s tailored approach extends beyond our standard service offerings. We validate and run Laboratory Developed Tests (LDTs) created to suit particular clinical needs. Our team can also assist manufacturers in optimising LDT performance, in line with requirements for submission to regulators.
Quality Assurance and Regulatory Compliance
Delivering reliable and high-quality data is InCytomix’s utmost priority. Our commitment to excellence is reflected in every facet of our operations, testing procedures, and reporting. InCytomix has embraced a rigorous quality management system, grounded in internationally recognised standards such as ISO 15189, GLP and GCLP. This adherence to quality standards ensures that we comply with all regulatory requirements, facilitate smooth regulatory submissions, and deliver data you can trust. Our meticulous approach guarantees that your research findings are robust, reliable, and poised for further development.
Our Genomic Services for Infectious Diseases
- Versatile Handling: Our efficient structure accommodates both small individual sample batches and extensive sets for clinical trials.
- Cutting-Edge Solutions: Utilising a broad array of advanced equipment, we offer precise diagnostics for molecular virology, bacteriology, and pathology.
- Broad Respiratory Pathogen Screening: We perform various singleplex or multiplex real-time PCR-based assays, detecting a wide array of respiratory viruses and bacterial pathogens.
Microbiome and Pathogen Discovery
- Whole Transcriptome Sequencing: A leading-edge approach to microbiome and pathogen discovery.
- Microbiome Analysis with 16S rDNA: Enhanced clinical development of anti-bacterial therapies through detailed bacterial strain analysis.
- Whole Genome Sequence Analysis: Support for epidemiological studies and targeted anti-bacterial therapy development, offered alongside traditional culture-based diagnostics.